Conversion disclosed
Erez Chimovits
Director
Common Stock
- Value context
- Unavailable
- Reported price
- Price not reported
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
ADARx Pharmaceuticals, Inc.
Last 30 daysInsiders bought $87.75M · 5 buyers, led by Sr One Capital Management (10% owner) with $27.2M. No qualifying insider sales.
Showing the first 6 of 20 trades on this page.
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Series A Preferred Stock
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Series B Preferred Stock
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Series B-1 Preferred Stock
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Series C Preferred Stock
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Series A Preferred Stock
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Series B Preferred Stock
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Series B-1 Preferred Stock
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Series C Preferred Stock
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Director | Common StockConversion | 7,127,019Price not reported | Unavailable | Sep 28Filed Sep 30 · 2d later | SEC filing |
| Director | Common StockConversion | 1,333,975Price not reported | Unavailable | Sep 28Filed Sep 30 · 2d later | SEC filing |
| Director | Common StockConversion | 513,067Price not reported | Unavailable | Sep 28Filed Sep 30 · 2d later | SEC filing |
| Director | Common StockConversion | 256,448Price not reported | Unavailable | Sep 28Filed Sep 30 · 2d later | SEC filing |
| Director | Series A Preferred StockConversion | Derivative units7,127,019Exercise / conversion price not reported | Not a separate purchase | Sep 28Filed Sep 30 · 2d later | SEC filing |
| Director | Series B Preferred StockConversion | Derivative units1,333,975Exercise / conversion price not reported | Not a separate purchase | Sep 28Filed Sep 30 · 2d later | SEC filing |
| Director | Series B-1 Preferred StockConversion | Derivative units513,067Exercise / conversion price not reported | Not a separate purchase | Sep 28Filed Sep 30 · 2d later | SEC filing |
| Director | Series C Preferred StockConversion | Derivative units256,448Exercise / conversion price not reported | Not a separate purchase | Sep 28Filed Sep 30 · 2d later | SEC filing |
| Director | Common StockConversion | 10,690,530Price not reported | Unavailable | Sep 28Filed Sep 30 · 2d later | SEC filing |
| Director | Common StockConversion | 2,000,962Price not reported | Unavailable | Sep 28Filed Sep 30 · 2d later | SEC filing |
| Director | Common StockConversion | 769,601Price not reported | Unavailable | Sep 28Filed Sep 30 · 2d later | SEC filing |
| Director | Common StockConversion | 564,187Price not reported | Unavailable | Sep 28Filed Sep 30 · 2d later | SEC filing |
| Director | Common StockConversion | 7,127,019Price not reported | Unavailable | Sep 28Filed Sep 30 · 2d later | SEC filing |
| Director | Common StockConversion | 1,333,975Price not reported | Unavailable | Sep 28Filed Sep 30 · 2d later | SEC filing |
| Director | Common StockConversion | 513,067Price not reported | Unavailable | Sep 28Filed Sep 30 · 2d later | SEC filing |
| Director | Common StockConversion | 256,448Price not reported | Unavailable | Sep 28Filed Sep 30 · 2d later | SEC filing |
| Director | Series A Preferred StockConversion | Derivative units10,690,530Exercise / conversion price not reported | Not a separate purchase | Sep 28Filed Sep 30 · 2d later | SEC filing |
| Director | Series B Preferred StockConversion | Derivative units2,000,962Exercise / conversion price not reported | Not a separate purchase | Sep 28Filed Sep 30 · 2d later | SEC filing |
| Director | Series B-1 Preferred StockConversion | Derivative units769,601Exercise / conversion price not reported | Not a separate purchase | Sep 28Filed Sep 30 · 2d later | SEC filing |
| Director | Series C Preferred StockConversion | Derivative units564,187Exercise / conversion price not reported | Not a separate purchase | Sep 28Filed Sep 30 · 2d later | SEC filing |
Showing the latest 20 of 81 trades. Show all 81 trades
This reflects the filings imported so far, not a complete trading history.
$87,745,772 of common-equity purchase value after transaction-age decay across 180 days.
5 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.
5 buying groups inside 30 transaction-date days, public by the snapshot cutoff.
At least one row increased reported same-security holdings by 10% or established a new reported position; indirect interests may overlap.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.